Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | -0.76% | +12.77% | +13.23% |
May. 01 | Cocrystal Pharma, Inc. Announces Completion of Enrollment of 78 Subjects | CI |
Mar. 28 | Cocrystal Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 12
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sam Lee
CEO | Chief Executive Officer | 64 | 14-01-01 |
James Martin
CEO | Chief Executive Officer | 58 | 17-02-22 |
Roger Kornberg
CHM | Chairman | 77 | 14-01-01 |
Luz Pascual
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Frost
BRD | Director/Board Member | 87 | 14-01-01 |
Director/Board Member | 68 | 21-05-26 | |
Steven Rubin
BRD | Director/Board Member | 63 | 14-01-01 |
Fred Hassan
BRD | Director/Board Member | 78 | 23-04-19 |
Anthony Japour
BRD | Director/Board Member | 64 | 19-04-03 |
Roger Kornberg
CHM | Chairman | 77 | 14-01-01 |
Sam Lee
CEO | Chief Executive Officer | 64 | 14-01-01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 10,173,790 | 7,118,978 ( 69.97 %) | 0 | 69.97 % |
Company contact information
Cocrystal Pharma, Inc.
19805 North Creek Parkway
98011, Bothell
+877 262 7123
http://www.cocrystalpharma.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.23% | 19.84M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.62% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- COCP Stock
- Company Cocrystal Pharma, Inc.